Skip to content

Clinical trials

Diabetes Mellitus trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Country / region: Brazil Clear all

204 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20039
20041
20053
200620
20078
20085
200911
201010
201111
201212
201315
20149
20155
201618
201714
20188
20193
20207
20214
20228
20238
20248
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed134
Unknown status40
Recruiting12
Terminated11
Withdrawn3
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S27
University of Sao Paulo21
Hospital de Clinicas de Porto Alegre18
Eli Lilly and Company12
University of Sao Paulo General Hospital12
AstraZeneca10
Takeda9
Pfizer6
Federal University of Rio Grande do Sul4
Universidade Estadual Paulista Júlio de Mesquita Filho4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus204
Diabetes Mellitus, Type 288
Hypertension19
Glucose Metabolism Disorders15
Diabetes Mellitus, Type 114
Obesity13
Dyslipidemias11
Insulin Resistance9
Metabolic Diseases9
Cardiovascular Diseases7

Trials

Showing 26 to 50 of 204. Each trial links to its page on Pharma Observatory.

104 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.